KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Discontinued OperationsCash from Discontinued OperationsCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Cash (2016 - 2026)

TherapeuticsMD filings provide 17 years of Change in Cash readings, the most recent being $936000.0 for Q1 2026.

  • On a quarterly basis, Change in Cash rose 36.44% to $936000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $2.7 million, a 90.05% increase, with the full-year FY2025 number at $2.4 million, up 231.15% from a year prior.
  • Change in Cash hit $936000.0 in Q1 2026 for TherapeuticsMD, up from $368000.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $12.0 million in Q3 2022 to a low of -$34.7 million in Q1 2022.
  • Median Change in Cash over the past 5 years was $12000.0 (2024), compared with a mean of -$3.3 million.
  • Biggest five-year swings in Change in Cash: plummeted 160.8% in 2022 and later soared 6136.36% in 2025.
  • TherapeuticsMD's Change in Cash stood at $11.0 million in 2022, then plummeted by 153.14% to -$5.8 million in 2023, then surged by 100.21% to $12000.0 in 2024, then surged by 2966.67% to $368000.0 in 2025, then skyrocketed by 154.35% to $936000.0 in 2026.
  • The last three reported values for Change in Cash were $936000.0 (Q1 2026), $368000.0 (Q4 2025), and $1.0 million (Q3 2025) per Business Quant data.